Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparels and aircrafts. The company also produces and sells toiletries; purchases and sells makeup products and vessels; and provides market research services. In addition, it provides air transportation, charter flights, ground handling, and hanger rental services; and aircraft flight training, as well as undertakes aviation-related operations. The company sells its products through drug stores, specialty goods and general merchandise stores, supermarkets, online stores, and convenience stores, as well as approximately 2,000 Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Tokyo, Japan.
Noevir Dividend Announcement
• Noevir announced a annually dividend of ¥0.00 per ordinary share which will be made payable on . Ex dividend date: 2025-09-29
• Noevir's trailing twelve-month (TTM) dividend yield is 4.49%
• Noevir's payout ratio for the trailing twelve months (TTM) is 100.71%
Noevir Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2025-09-29 | ¥0.00 | annually | |
2024-09-27 | ¥225.00 | annually | 2024-12-10 |
2023-09-28 | ¥220.00 | annually | 2023-12-11 |
2022-09-29 | ¥210.00 | annually | 2022-12-09 |
2021-09-29 | ¥205.00 | annually | 2021-12-07 |
2020-09-29 | ¥200.00 | annually | 2020-12-07 |
2019-09-27 | ¥200.00 | annually | 2019-12-06 |
2018-09-26 | ¥180.00 | annually | 2018-12-10 |
2017-09-27 | ¥150.00 | annually | 2017-12-08 |
2016-09-28 | ¥120.00 | annually | |
2015-09-28 | ¥100.00 | annually | |
2014-09-26 | ¥60.00 | annually |
Noevir Dividend per year
Noevir Dividend growth
Noevir Dividend Yield
Noevir current trailing twelve-month (TTM) dividend yield is 4.49%. Interested in purchasing Noevir stock? Use our calculator to estimate your expected dividend yield:
Noevir Financial Ratios
Noevir Dividend FAQ
Other factors to consider when evaluating Noevir as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Noevir stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Noevir's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Noevir publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Noevir distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Noevir are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Noevir sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Noevir distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Noevir declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Noevir's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Noevir's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.